Last A$72.94 AUD
Change Today +0.33 / 0.45%
Volume 1.4M
As of 2:10 AM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mary Sontrop B.Appsc, MBA

Executive Vice President of Manufacturing Operations & Planning, CSL Ltd.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 4 different industries.

As of Fiscal Year 2014


Ms. Mary Sontrop, B.Appsc, MBA serves as an Executive Vice President of Manufacturing & Planning of CSL Behring LLC and served as its Executive Vice President of Operations since April 2010. Ms. Sontrop has been an Executive Vice President of Operations at CSL Behring GmbH since April 2010. Ms. Sontrop headed CSL Behring's manufacturing facilities at Marburg (Germany) and Bern (Switzerland). Ms. Sontrop serves as an Executive Vice President of Operations of CSL Ltd. ...

Read Full Background

Corporate Headquarters*

45 Poplar Road
Parkville, Victoria 3052


Phone: 61 3 9389 1911
Fax: 61 3 9389 1434

Board Members Memberships*

There is no Board Members Memberships data available.


There is no Education data available.

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,056,651

Stock Options*

Restricted Stock Awards$281,518
Long Term Incentive Plan$168,960
All Other Compensation$427,902
Exercised Options4,350
Unexercisable Options37,790
Total Number of Options42,140

Total Compensation*

Total Annual Cash Compensation$1,484,553
Total Short Term Compensation$1,056,651
Other Long Term Compensation$709,420
Total Calculated Compensation$1,968,901
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CSL:AU A$72.94 AUD +0.33


Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
Victor Grifols Roura Chairman, Chief Executive Officer, President, Managing Director and Member of Appointments & Remuneration Committee
Grifols, S.A.
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CSL LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at